VR Treatment for Lazy Eye in Children Receives FDA Approval

VR Treatment for Lazy Eye in Children Receives FDA Approval

The Food and Drug Administration has approved a virtual reality-based treatment for children with visual impairment or lazy eyes. Patients watch movies and modified TV shows through a virtual reality headset to improve vision.

According to Scott Xiao, founder of Luminopia, this is the first digital therapy tool that allows patients to watch their favourite TV shows to improve their vision. Luminopia is the company that created the device.

About 3 per cent of children have amblyopia, which develops when the eyes and brain stop communicating properly. The brain prefers one look, which causes vision problems in the other eye. This, in turn, becomes a significant cause of vision problems in children. It is usually treated with a strong eye block or blurred drops that force the brain to rely on a weaker eye.

Luminopia’s approach involves films and television to develop the weak eye and work with the eyes together. Patients watch a show or movie through a headset that shows the images to each eye separately. Ideas for the more muscular look have lower contrast. Therefore the images are overlaid, forcing the brain to use both eyes to see them correctly.

Children who used therapy and wore glasses had more improvement insight than those who did not use therapy and only wore corrective glasses on a full-time basis. After 12 weeks of watching the show, 62 per cent of the children dramatically improved vision. It is noteworthy that only a third of the children in the comparison group had a similar improvement during this time.


Luminopia has partnered with Kids Content Distributors, Sesame Workshop and Nelvana to develop the tool. The authors of the clinical study wrote that they believe that choosing the option of popular videos could be one of the reasons why users stay in the program. The result was that 88% of people followed the treatment plan. Less than 50 per cent of patients have blurred drops.

Luminopia joins various companies to offer consumers digital therapies for healing. The FDA last year approved a video game called EndeavorRx that treats ADHD in children ages 8-12. A statement from Luminopia said the company plans to begin treatment in 2022.

The company’s first show seems to have paid off. Therefore, there is an excellent chance that by 2022 virtual reality-based treatment will change the lives of too many children for the better.

For more news updates, visit our homepage now and see our latest news article. Want to learn more about trading? Visit our education page now and learn for FREE!

Leave a Reply

User Review
  • Support
  • Platform
  • Spreads
  • Trading Instument